Scientific Opinion on the modification of the authorisation of a health claim related to water-soluble tomato concentrate and helps to maintain a healthy blood flow and benefits circulation pursuant to Article 13(5) of Regulation (EC) No 1924/2006 following a request in accordance with Article 19 of the Regulation (EC) No 1924/2006

EFSA Journal

Volumn 8, Issue 7, 2010, Pages

[No Author Info available]

Author keywords

adults; clotting time; conditions of use; health claims; platelet aggregation; water soluble tomato concentrate

Indexed keywords

EID: 85078372018     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2010.1689     Document Type: Article

References (2)

1. EFSA (European Food Safety Authority), 2009. Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific substantiation of a health claim related to water-soluble tomato concentrate (WSTC I and II) and platelet aggregation pursuant to Article 13(5) of Regulation (EC) No 1924/2006. The EFSA Journal, 1101, 1–15.
2. O'Kennedy N, Crosbie L, Greyling A, de Bree A, Kroner CK, Arthur JA and Duttaroy AK, 2007. A randomised, controlled and double-blinded crossover study to compare the antiplatelet effects of three different formats of WSTC in healthy humans. REC No. 07/S0801/13.